Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this study, researchers found that hair alterations such as frontal-occipital inversion in males and a high occipital hairline may aid in diagnosing the uncommon condition TRPS.

This study suggests that a prototype device may accurately measure hair quantity, diameter, and density in balding patients, potentially aiding in diagnostic assessments, though formal clinical studies are needed to confirm its effectiveness.

This review discusses trichotillomania, including its diagnosis and management, and emphasizes the importance of a psychiatry-dermatology liaison alongside behavioral therapy and pharmacological options.

Trichoscopy helps diagnose and manage different types of hair loss effectively.

This review discusses the use of trichoscopy in diagnosing and managing pediatric hair and scalp disorders and reports no new experimental findings.

This review presents European expert guidelines for diagnosing androgenetic alopecia across genders but reports no new clinical findings; it emphasizes the importance of trichoscopy for differentiating similar conditions.

This review addresses the complexities in trichoscopy terminology and proposes an updated diagnostic flowchart for hair diseases, but it reports no new clinical findings.

This article discusses a hypothetical model of androgenic hair trichophore composed of various chemical components, but it reports no new empirical findings; the authors emphasize the model's potential impact on hair cosmetics.

This pilot study detailed the use of Hair-to-Hair-matching technology™ in a clinical trial to assess botulinum toxin's efficacy in treating male androgenetic alopecia, providing a precise method for evaluating hair count and thickness changes over time.

This article reviews various self-aggressive hair disorders such as trichotillomania and emphasizes the psychiatric aspects of these conditions, but reports no new clinical findings.

This study describes characteristic trichoscopic features of various hair loss diseases and proposes an algorithmic method for diagnosing them, but reports no new clinical results.

In this literature review, researchers highlighted that trichotillomania involves dysregulated reward circuits, abnormal sensory processing, and potential genetic factors, advancing both therapeutic strategies and understanding of the condition, but stigma and provider training gaps persist in effective care provision.

In this study, trichoscopy was found to be a valuable non-invasive tool for diagnosing scalp lesions, enhancing diagnostic accuracy and reducing the need for scalp biopsies by identifying specific trichoscopic features associated with conditions like psoriasis, seborrheic dermatitis, and alopecia areata.

This article reviews the development of trichophytic closure techniques in hair restoration surgery aimed at reducing donor site scarring, but it does not report new clinical outcomes.

This commentary discusses the rarity of "triangular alopecia" in hair restoration surgery and highlights the lack of mention in professional settings, without providing new clinical data.

Androgenetic alopecia is the only hair loss condition with specific diagnostic criteria in trichoscopy.

This review evaluates various cognitive-behavioral interventions for trichotillomania but does not report new clinical findings, highlighting the need for further research on their efficacy.

This study found that trichoscopy is an effective method for monitoring treatment response in androgenetic alopecia when conducted by doctors experienced in hair diseases, showing excellent agreement with TrichoScan measurements for various hair parameters.

This review discusses trichoscopy as a noninvasive, effective technique for diagnosing various hair loss conditions and monitoring treatment, highlighting its potential to reduce scalp biopsy necessity.

Hair styling products can damage hair over time.

This study evaluated a herbal anti-dandruff hair wash powder, TRICHONEMTM, composed of eighteen herbal ingredients, reporting effective in vitro anti-dandruff activity and high user satisfaction in a 4-week pilot trial involving 50 women, without causing irritation.

Fear of hair-related issues causes significant mental distress, especially in high-stress women.

This review from JAAD Reviews provides a comprehensive overview of hypertrichosis, discussing its diagnosis, treatment options like topical and laser therapies, and special psychosocial considerations for pediatric patients to better support clinicians and researchers in managing this condition.

This review discusses recent advancements in behavioral and pharmacological treatments for trichotillomania but does not report new clinical results, emphasizing the need for rigorous future research.

This review examines psychosomatic hair diseases, discussing their classification, implications, and the need for tailored psychosomatic therapy, without reporting new clinical results.

This study outlines trichodynia, a painful scalp condition often linked with various types of alopecia and psychiatric disorders, noting the absence of specific treatments and highlighting the need for further research on therapeutic options.

Trichoscopy is a helpful and quick method to diagnose hair loss without shaving.

This review explores emerging 3D bioprinting strategies for hair follicle creation, highlighting their potential to advance alopecia treatment and trichology research, but notes the need for further optimization and reduced maintenance costs before clinical use.

In this review, the authors concluded that trichoscopy is a quick, non-invasive, and effective method for diagnosing and monitoring non-scarring alopecia, offering a more precise and faster alternative compared to other diagnostic methods for identifying and managing different types of hair loss.

This study found trichoscopy to be a reliable non-invasive method for diagnosing various forms of alopecia, aiding in clinical management and reducing the need for biopsies in a hospital-based setting with 90 patients, including those with uncertain diagnoses.